Literature DB >> 7137154

Mortality related to diabetes and blood glucose levels in a community study.

J B O'Sullivan, C M Mahan.   

Abstract

A prospective 29-year population study of diabetes in Oxford, MA, is the basis for a case-control analysis of diabetes mortality rates and their validity. Two case groups were considered, one consisting of previously known diabetics at the study's inception in 1946 and the other defined by hyperglycemia above 140 mg/dl. Mortality rates were significantly higher for diabetics than for age- and sex-matched controls, and disproportionately higher for women largely due to the advantageous mortality experience of nondiabetic women compared to nondiabetic men. Estimated survival experience showed longevity to be shorter by some 10 to 15 years for the female and six to nine years for the male diabetic. Mortality rates were also significantly higher for the hyperglycemic group than for matched controls. Although deaths from cardiovascular causes were predominant, they proved significantly higher for women with known diabetes only. Substantial underreporting of diabetes on the death certificates persisted in every decade of the study. The proportion of prevalent and incident cases of diabetes during the 19-year period of the study, whose diagnosis failed to appear anywhere on the death certificate, was found to be at or above 50%. Among subjects with death certificates that did not list diabetes, 4.4 to 14.1% were known to have diabetes, based on the underlying composition of the sample. Prevalent cases of diabetes had a higher reporting rate than incident cases, suggesting that duration of diabetes may also be a factor in such rates.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7137154     DOI: 10.1093/oxfordjournals.aje.a113450

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

1.  Certification of cause of death in French diabetic patients.

Authors:  B Balkau; L Papoz
Journal:  J Epidemiol Community Health       Date:  1992-02       Impact factor: 3.710

2.  Genome-wide association study identifies common loci influencing circulating glycated hemoglobin (HbA1c) levels in non-diabetic subjects: the Long Life Family Study (LLFS).

Authors:  Ping An; Iva Miljkovic; Bharat Thyagarajan; Aldi T Kraja; E Warwick Daw; James S Pankow; Elizabeth Selvin; W H Linda Kao; Nisa M Maruthur; Micahel A Nalls; Yongmei Liu; Tamara B Harris; Joseph H Lee; Ingrid B Borecki; Kaare Christensen; John H Eckfeldt; Richard Mayeux; Thomas T Perls; Anne B Newman; Michael A Province
Journal:  Metabolism       Date:  2013-12-04       Impact factor: 8.694

Review 3.  Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  G Panzram
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

4.  Lidocaine improves survival rate in diabetic rats submitted to acute left coronary artery ligation.

Authors:  S Rousseau-Migneron; G Tancrède; A Nadeau
Journal:  Basic Res Cardiol       Date:  1990 Jul-Aug       Impact factor: 17.165

5.  Cardiovascular mortality in non-insulin-dependent diabetes mellitus. A controlled study among 683 diabetics and 683 age- and sex-matched normal subjects.

Authors:  E Casiglia; G Zanette; A Mazza; V Donadon; C Donada; A Pizziol; V Tikhonoff; P Palatini; A C Pessina
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

6.  Underreporting of diabetes on death certificates, King County, Washington.

Authors:  E M Andresen; J A Lee; R E Pecoraro; T D Koepsell; A P Hallstrom; D S Siscovick
Journal:  Am J Public Health       Date:  1993-07       Impact factor: 9.308

7.  Diabetes mortality: new light on an underestimated public health problem.

Authors:  J H Fuller; J Elford; P Goldblatt; A M Adelstein
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

8.  Changing mortality patterns in Nauruans: an example of epidemiological transition.

Authors:  M Schooneveldt; T Songer; P Zimmet; K Thoma
Journal:  J Epidemiol Community Health       Date:  1988-03       Impact factor: 3.710

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.